SAMSUNG BIOLOGICS Forecast, price target & analysts
SAMSUNG BIOLOGICS Target price 2025 - Analyst rating & recommendation
SAMSUNG BIOLOGICS Classifications & Recommendation:
SAMSUNG BIOLOGICS Price Target
| Target Price | KRW1,310,080.00 |
| Price | KRW1,000,000.00 |
| Potential |
31.01%
register free of charge
|
| Number of Estimates | 24 |
|
24 Analysts have issued a price target SAMSUNG BIOLOGICS 2026 .
The average SAMSUNG BIOLOGICS target price is KRW1,310,080.00.
This is
31.01%
register free of charge
KRW1,430,000.00
43.00%
register free of charge
KRW1,190,000.00
19.00%
register free of charge
|
|
| A rating was issued by 25 analysts: 24 Analysts recommend SAMSUNG BIOLOGICS to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the SAMSUNG BIOLOGICS stock has an average upside potential 2026 of
31.01%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion KRW | 4,547.32 | 5,657.14 |
| 23.08% | 24.41% | |
| EBITDA Margin | 42.20% | 39.08% |
| 2.76% | 7.40% | |
| Net Margin | 23.82% | 22.63% |
| 2.62% | 5.00% |
23 Analysts have issued a sales forecast SAMSUNG BIOLOGICS 2025 . The average SAMSUNG BIOLOGICS sales estimate is
This results in the following potential growth metrics:
23 Analysts have issued an SAMSUNG BIOLOGICS EBITDA forecast 2025. The average SAMSUNG BIOLOGICS EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
7 SAMSUNG BIOLOGICS Analysts have issued a net profit forecast 2025. The average SAMSUNG BIOLOGICS net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share KRW | 15,220.67 | 17,989.38 |
| 26.31% | 18.19% | |
| P/E | 55.59 | |
| EV/Sales | 13.36 |
7 Analysts have issued a SAMSUNG BIOLOGICS forecast for earnings per share. The average SAMSUNG BIOLOGICS EPS is
This results in the following potential growth metrics and future valuations:
SAMSUNG BIOLOGICS...
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
